Sevoflurane Patent Expiration
Sevoflurane was first introduced by Abbvie Inc
Sevoflurane Patents
Given below is the list of patents protecting Sevoflurane, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ultane |
US6074668 (Pediatric) | Container for an inhalation anesthetic |
Jul 09, 2018
(Expired) | Abbvie |
| Ultane | US6074668 | Container for an inhalation anesthetic |
Jan 09, 2018
(Expired) | Abbvie |
| Ultane |
US5990176 (Pediatric) | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul 27, 2017
(Expired) | Abbvie |
| Ultane |
US6288127 (Pediatric) | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul 27, 2017
(Expired) | Abbvie |
| Ultane |
US6444859 (Pediatric) | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul 27, 2017
(Expired) | Abbvie |
| Ultane | US5990176 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan 27, 2017
(Expired) | Abbvie |
| Ultane | US6288127 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan 27, 2017
(Expired) | Abbvie |
| Ultane | US6444859 | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan 27, 2017
(Expired) | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Sevoflurane's patents.
Latest Legal Activities on Sevoflurane's Patents
Given below is the list recent legal activities going on the following patents of Sevoflurane.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical
| 03 Sep, 2002 | US6444859 |
| Recordation of Patent Grant Mailed Critical
| 03 Sep, 2002 | US6444859 |
| Issue Notification Mailed Critical
| 15 Aug, 2002 | US6444859 |
| Receipt into Pubs | 06 Aug, 2002 | US6444859 |
| Application Is Considered Ready for Issue Critical
| 05 Aug, 2002 | US6444859 |
| Receipt into Pubs | 02 Aug, 2002 | US6444859 |
| Response to Amendment under Rule 312 Critical
| 30 Jul, 2002 | US6444859 |
| Mail Response to 312 Amendment (PTO-271) Critical
| 30 Jul, 2002 | US6444859 |
| Receipt into Pubs | 01 Jul, 2002 | US6444859 |
| Issue Fee Payment Verified Critical
| 18 Jun, 2002 | US6444859 |
Sevoflurane's Family Patents
